Bavarian Nordic Overview
Company Headquarters: Denmark, Europe
Founded: 1992
Workforce: ~1000
Company Working: Bavarian Nordic is a fully integrated vaccines company focused on R&D innovation, vaccine manufacturing, and vaccine commercialization. It has built a commercial infrastructure with a presence in key countries in Europe and the US in order to drive profitable expansion of its expanding vaccine portfolio. The company is an expert in the production of live viral vaccines, and the fill & finish capabilities has enabled end-to-end commercial-scale production
Strategy
Bavarian Nordic unveiled a five-year strategy in 2020. Building on its core strengths in vaccine research, development, and manufacturing, it accelerated its growth through a strategic product acquisition and organizational expansion to include a full, global commercial infrastructure, transforming itself into a full-fledged vaccine company with the goal of becoming one of the largest pure play vaccine companies by 2025, with annual revenues exceeding USD 1 billion



